Chronic Kidney Disease with Mineral Bone Disorder and Vascular Calcification: An Overview

Carmine Izzo,Carmine Secondulfo,Giancarlo Bilancio,Valeria Visco,Nicola Virtuoso,Serena Migliarino,Michele Ciccarelli,Paola Di Pietro,Lucia La Mura,Antonio Damato,Albino Carrizzo,Carmine Vecchione

DOI: https://doi.org/10.3390/life14030418

2024-03-22

Life

Abstract:Chronic kidney disease (CKD) is a global health issue with a rising prevalence, affecting 697.5 million people worldwide. It imposes a substantial burden, contributing to 35.8 million disability-adjusted life years (DALYs) and 1.2 million deaths in 2017. The mortality rate for CKD has increased by 41.5% between 1990 and 2017, positioning it as a significant cause of global mortality. CKD is associated with diverse health complications, impacting cardiovascular, neurological, nutritional, and endocrine aspects. One prominent complication is CKD–mineral and bone disorder (MBD), a complex condition involving dysregulation of bone turnover, mineralization, and strength, accompanied by soft tissue and vascular calcification. Alterations in mineral metabolism, including calcium, phosphate, parathyroid hormone (PTH), vitamin D, fibroblast growth factor-23 (FGF-23), and Klotho, play pivotal roles in CKD-MBD. These disturbances, observed early in CKD, contribute to the progression of bone disorders and renal osteodystrophy (ROD). Vascular calcification (VC) is a key component of CKD-MBD, accelerated by CKD. The pathophysiology involves complex processes in vascular smooth muscle cells and the formation of calciprotein particles (CPP). VC is closely linked to cardiovascular events and mortality, emphasizing its prognostic significance. Various serum markers and imaging techniques, including lateral plain X-ray, Kauppila Score, Adragao Score, and pulse wave velocity, aid in VC detection. Additionally, pQCT provides valuable information on arterial calcifications, offering an advantage over traditional scoring systems. CKD poses a substantial global health burden, and its complications, including CKD-MBD and VC, significantly contribute to morbidity and mortality. Understanding the intricate relationships between mineral metabolism, bone disorders, and vascular calcification is crucial for effective diagnosis and therapeutic interventions.

biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the complex relationship between chronic kidney disease (CKD), mineral and bone disorder (MBD), and vascular calcification (VC). Specifically, the research aims to explore the following issues:

1. **Epidemiology and Incidence of CKD**: CKD is a global health problem, and its incidence is increasing year by year. It has affected 697.5 million people worldwide and has led to 35.8 million DALYs (disability - adjusted life years) and 1.2 million deaths. With the increase in the incidence of CKD, how to effectively manage and treat this disease has become an urgent problem to be solved.

2. **Pathophysiological Mechanisms of CKD - MBD**: CKD - MBD is a complex condition, involving the dysregulation of bone turnover, mineralization, and strength, accompanied by soft - tissue and vascular calcification. The article discusses in detail the changes in mineral metabolism (such as calcium, phosphorus, parathyroid hormone PTH, vitamin D, fibroblast growth factor - 23 (FGF - 23), and Klotho protein) and their impact on CKD - MBD.

3. **Pathophysiological Mechanisms of Vascular Calcification**: Vascular calcification is a key component of CKD - MBD, especially accelerating in the early stages of CKD. The article explores the process of the transformation of vascular smooth muscle cells into a secretory phenotype and the resulting mechanism of arterial calcification. In addition, it also discusses the formation of calcium - phosphorus nanocomplexes and their role in vascular calcification.

4. **Diagnostic Tools and Techniques**: In order to better understand and manage CKD - MBD and VC, the article introduces the application of various serum markers (such as FGF - 23, Klotho, alkaline phosphatase, bone - specific alkaline phosphatase BSAP, P1NP, osteocalcin, Sclerostin, TRAP5b, etc.) and imaging techniques (such as X - ray plain film, Kauppila score, Adragao score, pulse wave velocity, pQCT, HRpQCT, MRI, etc.).

5. **Clinical Significance and Treatment Strategies**: CKD - MBD and VC are closely related to cardiovascular events and all - cause mortality. Therefore, understanding the mechanisms of these complications is crucial for formulating effective diagnostic and treatment strategies. The article emphasizes the necessity of optimizing mineral metabolism, controlling bone turnover, and preventing vascular calcification.

In summary, this review aims to comprehensively analyze the pathophysiological mechanisms of CKD - MBD and VC, evaluate the existing diagnostic tools and techniques, and provide guidance for future treatment strategies.